KLRS

Latest SEC Filings & News for KLRS

1 most recent filing and news item mentioning KLRS. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/KLRS/news?limit=20"

Pull KLRS filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

OtherJul 17, 2026Positive

Kalaris reports positive Phase 1a results for TH103 in neovascular AMD

Kalaris Therapeutics reported extended retention and vision improvements in Phase 1a TH103 trials for neovascular AMD. The delayed time to retreatment suggests potential differentiation against existing anti-VEGF therapies.

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.